Skip to main content
Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
9.86
+0.08 (0.82%)
Nov 13, 2026, 4:00 PM EST - Market closed

Contineum Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-63.46-59.98-42.2622.72-24.25-29
Depreciation & Amortization
0.380.320.260.20.330.33
Other Amortization
-----0.15
Loss (Gain) From Sale of Assets
00.07-0.02-0-
Loss (Gain) From Sale of Investments
-0.69-0.8-3.95-2.660.250.39
Stock-Based Compensation
1510.046.82.221.931.75
Other Operating Activities
1.931.080.98-2.112.90.01
Change in Accounts Payable
-0.2-0.871.14--0.23-0.11
Change in Other Net Operating Assets
-4.83-5.174.19-1.02-1.040.22
Operating Cash Flow
-51.87-55.31-32.8519.35-20.12-26.27
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.36-0.23-0.51-0.41-0.12-0.17
Sale of Property, Plant & Equipment
--0.02---
Investment in Securities
-30.59-3.48-69.25-65.1522.42-64.8
Investing Cash Flow
-30.95-3.71-69.74-65.5722.3-64.97

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----3.75-1.25-
Net Debt Issued (Repaid)
----3.75-1.25-
Issuance of Common Stock
115.45112.941090.160.020.11
Repurchase of Common Stock
----0.03-0-
Other Financing Activities
-0.06-0.26--0.34--
Financing Cash Flow
115.39112.6910956.18-1.2479.84

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
32.5753.666.429.960.94-11.4

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-52.23-55.54-33.3618.94-20.24-26.43
Free Cash Flow Growth
------
Free Cash Flow Margin
---37.87%--
Free Cash Flow Per Share
-1.45-2.00-1.725.58-9.02-12.53
Levered Free Cash Flow
-32.55-36.92-20.8713.08-12.61-
Unlevered Free Cash Flow
-32.55-36.92-20.8713.21-12.37-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---0.150.230.22
Cash Income Tax Paid
---0.45--
Change in Working Capital
-5.04-6.045.33-1.02-1.270.11
SEC Filings: 10-K · 10-Q